CollPlant Biotechnologies (CLGN) Enterprise Value (2018 - 2025)
CollPlant Biotechnologies' Enterprise Value history spans 8 years, with the latest figure at -$5.9 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 51.06% year-over-year to -$5.9 million; the TTM value through Dec 2025 reached -$5.9 million, up 51.06%, while the annual FY2025 figure was -$5.9 million, 51.06% up from the prior year.
- Enterprise Value reached -$5.9 million in Q4 2025 per CLGN's latest filing, up from -$12.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$5.9 million in Q4 2025 to a low of -$29.7 million in Q4 2022.
- Average Enterprise Value over 5 years is -$17.6 million, with a median of -$13.1 million recorded in 2021.
- Peak YoY movement for Enterprise Value: plummeted 272.89% in 2021, then surged 54.83% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$13.1 million in 2021, then crashed by 125.71% to -$29.7 million in 2022, then increased by 9.3% to -$26.9 million in 2023, then soared by 54.83% to -$12.2 million in 2024, then surged by 51.06% to -$5.9 million in 2025.
- Per Business Quant, the three most recent readings for CLGN's Enterprise Value are -$5.9 million (Q4 2025), -$12.2 million (Q4 2024), and -$26.9 million (Q4 2023).